Search for a trial | Research with human participants

1 results

An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK1/2/3, ROS1, or ALK Gene Rearrangements

Approved WMORecruiting

This study has been transitioned to CTIS with ID 2023-505034-10-00 check the CTIS register for the current data. To determine the objective response rate of entrectinib, as assessed by BICR, in each patient population basket of solid tumors that…